Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 3, 2005, Pages 450-455

  Chen, Chien Ting ^a,b   Chu, Chi Jen ^a,b   Wang, Teh Fang ^c   Lu, Rei Hwa ^a   Lee, Fa Yauh ^a,b,d   Chang, Full Young ^a,b   Lin, Han Chieh ^a,b   Chan, Che Chang ^a,b   Wang, Sun Sang ^b,e   Huang, Hui Chun ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Armed Forces Sung Shan Hospital   (Taiwan)

^d Internal Medicine   (Taiwan)

^e TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

Author keywords

Endotoxin; Fulminant hepatic failure; Hepatic encephalopathy; Polymyxin B; Thioacetamide

Indexed keywords

ENDOTOXIN; POLYMYXIN B; SODIUM CHLORIDE; THIOACETAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATIC ENCEPHALOPATHY; LIVER FAILURE; LOW DRUG DOSE; MALE; MOTOR ACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 20144388763     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03550.x     Document Type: Article

References (46)

1. Gammal SH, Jones EA. Hepatic encephalopathy. Med. Clin. North Am. 1989; 73: 793-813.
2. Sherlock S. Fulminant hepatic failure. Adv. Intern. Med. 1993; 38: 245-67.
3. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Soc. Exp. Biol. Med. 1994; 206: 329-44.
4. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu. Rev. Med. 1987; 38: 417-32.
5. Sprung CL, Cerra FB, Freund HR et al. Amino acid alternations and encephalopathy in the sepsis syndrome. Crit. Care Med. 1991; 19: 753-7.
6. Kilpatrick-Smith L, Yoder MC, Polin RA, Douglas SD, Erecinska M. Endotoxin-induced changes in nitrogen metabolism. Res. Commun. Chem. Path. 1986; 53: 381-98.
7. Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet 1975; 1: 1272-4.
8. Bigatello LM, Broitman SA, Fattori L et al. Endotoxemia, encephalopathy and mortality in cirrhotic patients. Am. J. Gastroenterol. 1987; 82: 11-15.
9. Old LI. Tumor necrosis factor (TNF). Science 1985; 230: 630-2.
10. Beutler B, Milsaark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869-71.
11. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-4.
12. Grau GE, Piquet PF, Vassalli P, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 1989; 112: 49-70.
13. Hoyumpa AMJ, Desmond PV, Avant GR, Roberts RK, Schenker S. Clinical conference: hepatic encephalopathy. Gastroenterology 1979; 78: 184-95.
14. Martinez A. Electron microscopy in human hepatic encephalopathy. Acta Neuropathol. 1968; 11: 82-6.
15. Chu CJ, Chen CT, Wang SS et al. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumour necrosis factor-α. J. Chin. Med. Assoc. 2001; 64: 321-30.
16. Odeh M. Endotoxin and tumor necrosis factor-α in the pathogenesis of hepatic encephalopathy. J. Clin. Gastroenterol. 1994; 19: 146-53.
17. Albrecht J, Hilgier W, Rafalowska U. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptive response? J. Neurosci. Res. 1990; 25: 125-30.
18. Osada J, Aylagas H, Miro-Obradors MJ, Arce C, Palacios-Alaiz E, Cascales M. Effect of acute thioacetamide administration on brain phospholipid metabolism. Neurochem. Res. 1990; 15: 927-31.
19. Zimmermann C, Ferenci P, Pifl C et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acidergic neurotransmission. Hepatology 1989; 9: 594-601.
20. Yurdaydin C, Hortnagl H, Stiendl P et al. Increased serotonergic and nonadrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology 1990; 12: 695-700.
21. Chu CJ, Lee FY, Wang SS et al. Establishment of an animal model of hepatic encephalopathy. J. Chin. Med. Assoc. 2000; 63: 263-9.
22. Chu CJ, Lee FY, Wang SS et al. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension. J. Hepatol. 1999; 30: 1105-11.
23. Gammal S, Basile AS, Geller D, Skolnick P, Jones EA. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 1990; 11: 371-8.
24. A-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology 1991; 14: 963-8.
25. Bengtsson F, Gage FH, Jeppsson B, Nobin A, Rosengren E. Brain monoamine metabolism and behaviour in portacaval shunted rats. Exp. Neurol. 1985; 90: 21-35.
26. Ribeiro J, Nordlinger B, Ballet F et al. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology 1992; 15: 12-18.
27. Lee FY, Wang SS, Yang MCM et al. Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J. Gastroenterol. Hepatol. 1996; 11: 152-8.
28. Fukui H, Brauner B, Bode JC, Bode C. Chromogenic endotoxin assay in plasma selection of plasma pretreatment and production of standard curves. J. Clin. Chem. Clin. Biochem. 1989; 27: 941-6.
29. Chu CJ, Lee FY, Wang SS et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-α and nitric oxide. Clin. Sci. 1997; 93: 219-25.
30. Ruiter DJ, Van der Meulen J, Brouwer A et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 1981; 45: 38-45.
31. Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharide by macrophages from normal and endotoxin-hyporesponsive mice. Infect. Immun. 1985; 48: 464-73.
32. Fukuda I, Tanamoto K, Kanegasaki S, Yajima Y, Goto Y. Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro. Br. J. Exp. Pathol. 1989; 70: 267-74.
33. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-75.
34. Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol. Today 1992; 13: 271-6.
35. Galanos C, Luderitz O, Rietschel ET et al. Synthetic and Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 1985; 148: 1-5.
36. Hughes B, Madan BR, Parratt JR. Polymyxin B sulphate protects cats against the hemodynamic and metabolic effects of E. coli endotoxin. Br. J. Pharmacol. 1981; 74: 701-7.
37. Form AH, Fong JS, Good RA. Polymyxin B sulphate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. Infect. Immun. 1979; 23: 660-4.
38. Flynn PM, Shenep JL, Stokes DC, Fairclough D, Hildner WK. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia. J. Infect. Dis. 1987; 156: 706-12.
39. Endo S, Inada K, Kikuchi M et al. Clinical effects of intramuscular administration of a small dose of polymyxin B to patients with endotoxemia. Res. Comm. Chem. Path. 1994; 83: 223-35.
40. Endo S, Inada K, Inoue Y et al. Treatment of endotoxemia with low-dose intramuscular injection or oral administration of polymyxin B. Clin. Ther. 1992; 14: 64-7.
41. Baldwin G, Alpert G, Caputo GL et al. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J. Infect. Dis. 1991; 164: 542-9.
42. Corrigan JJ, Kiernat JF. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative specticemia model. Pediatr. Res. 1979; 13: 48-51.
43. Lopes J, Inniss WE. Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide. J. Bacteriol. 1969; 100: 1128-30.
44. Tarmina DF, Milner KC, Ribi E, Rudbach JA. Reaction of endotoxin and surfactants. II. Immunological properties of endotoxin treated with sodium deoxycholate. J. Immunol. 1968; 100: 444-50.
45. Di Luzio NR, Trejo RA, Crafton CC. Influence of endotoxin administration on hepatic function of rats with altered endotoxin sensitivity. J. Reticuloendothel. Soc. 1972; 11: 637-53.
46. Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1981; 1: 458-65.